Pretreatment with cilnidipine attenuates hypoxia/reoxygenation injury in HL-1 cardiomyocytes through enhanced NO production and action potential shortening

• Published in: Hypertension research 2020-05, Vol.43 (5), p.380-388
• Main Authors: Minato, Hiroyuki, Hisatome, Ichiro, Kurata, Yasutaka, Notsu, Tomomi, Nakasone, Naoe, Ninomiya, Haruaki, Hamada, Toshihiro, Tomomori, Takuya, Okamura, Akihiro, Miake, Junichiro, Tsuneto, Motokazu, Shirayoshi, Yasuaki, Endo, Ryo, Otsuki, Akihiro, Okada, Futoshi, Inagaki, Yoshimi
• Format: Article
• Language: English
• Subjects: Apoptosis; Hypertension; Hypoxia; Ischemia; Nitric oxide
• ISSN: 0916-9636; 1348-4214
• DOI: 10.1038/s41440-019-0391-7

Myocardial ischemia/reperfusion injury worsens in the absence of nitric oxide synthase (NOS). Cilnidipine, a Ca channel blocker, has been reported to activate endothelial NOS (eNOS) and increases nitric oxide (NO) in vascular endothelial cells. We examined whether pretreatment with cilnidipine could attenuate cardiac cell deaths including apoptosis caused by hypoxia/reoxygenation (H/R) injury. HL-1 mouse atrial myocytes as well as H9c2 rat ventricular cells were exposed to H/R, and cell viability was evaluated by an autoanalyzer and flow cytometry; eNOS expression, NO production, and electrophysiological properties were also evaluated by western blotting, colorimetry, and patch clamping, respectively, in the absence and presence of cilnidipine. Cilnidipine enhanced phosphorylation of eNOS and NO production in a concentration-dependent manner, which was abolished by siRNAs against eNOS or an Hsp90 inhibitor, geldanamycin. Pretreatment with cilnidipine attenuated cell deaths including apoptosis during H/R; this effect was reproduced by an NO donor and a xanthine oxidase inhibitor. The NOS inhibitor L-NAME abolished the protective action of cilnidipine. Pretreatment with cilnidipine also attenuated H9c2 cell death during H/R. Additional cilnidipine treatment during H/R did not significantly enhance its protective action. There was no significant difference in the protective effect of cilnidipine under normal and high Ca conditions. Action potential duration (APD) of HL-1 cells was shortened by cilnidipine, with this shortening augmented after H/R. L-NAME attenuated the APD shortening caused by cilnidipine. These findings indicate that cilnidipine enhances NO production, shortens APD in part by L-type Ca channel block, and thereby prevents HL-1 cell deaths during H/R.